Oncternal Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 28, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1,107	975	539	-	-	-
Market Cap Growth	80.98%	80.98%	-	-	-	-
Enterprise Value	1,028	960	538	-	-	-
Last Close Price	207.00	196.35	110.00	-	-	-
PE Ratio	17.50	15.41	33.92	-	-	-
PS Ratio	1.79	1.58	3.03	-	-	-
PB Ratio	3.99	3.52	2.96	-	-	-
P/TBV Ratio	4.00	3.52	2.96	-	-	-
P/OCF Ratio	97.21	85.62	-	-	-	-
EV/Sales Ratio	1.66	1.56	3.02	-	-	-
EV/EBITDA Ratio	11.56	10.81	23.72	-	-	-
EV/EBIT Ratio	11.59	10.83	23.81	-	-	-
Debt / Equity Ratio	0.12	0.12	0.09	0.16	0.49	-
Debt / EBITDA Ratio	0.37	0.37	0.71	0.38	1.43	-
Debt / FCF Ratio	-	-	-	1.70	-	-
Asset Turnover	2.19	2.19	1.26	2.73	4.78	-
Inventory Turnover	10.01	10.01	6.43	48.23	59.40	-
Quick Ratio	3.35	3.35	4.70	1.67	1.40	0.82
Current Ratio	4.32	4.32	7.92	1.80	1.65	1.42
Return on Equity (ROE)	27.55%	27.55%	14.76%	66.43%	38.36%	-
Return on Assets (ROA)	19.67%	19.67%	10.03%	18.90%	9.58%	-
Return on Capital (ROIC)	21.81%	21.81%	11.93%	35.27%	18.57%	-
Return on Capital Employed (ROCE)	31.80%	31.80%	12.40%	41.00%	33.10%	43.70%
Earnings Yield	5.72%	6.49%	2.95%	-	-	-
FCF Yield	-0.43%	-0.49%	-7.24%	-	-	-
Buyback Yield / Dilution	-87.69%	-87.69%	17.36%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.